Liven Pharma Limited - LIVEN

Rs 36.13

Change -2.82

On Apr 30

Trades end of day

Last trade on Apr 30, 2026 Day's range Rs 35.51 - 38.95
Change Rs -2.82 52 week range Rs 27.82 - 80.80
Open Rs 38.95 Volume 144,625
Close Rs 36.13 Previous Close Rs 36.13

LIVEN Company Meetings

No Meetings
 

LIVEN Trade Activity

Period High Low Volume
1M 42.66 33.14 4,294,472.00; Avg 204,498.67
3M 54.15 28.85 13,409,589.00; Avg 219,829.33
6M 67.10 28.85 27,114,933.00; Avg 216,919.46
1Y 76.85 28.85 97,947,558.00; Avg 388,680.79
 
 

Latest Annual Financials

Financial Year O/S Shares 0.00m
Net Profit Rs 0.00m Market Cap Rs 0.00m
EPS 0.00 P/E 0.00
Par Value Rs 0.00 Book Value 0.00
Net Worth Rs 0.00m Outstanding Shares 0.00m
Dividend Rs 0.00 ROE 0.00%
Dividend Yield 0.00% Divident Payout 0.00%
Earnings Yield 0.00% Sharia No
 

Price Chart

Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools, stock screener and real time economic calendar data to track key financial events.

 

The company is in the Pharmaceuticals sector.

 

Other Companies in This Sector

Company Current Change Date
Abbot Laboratories Rs 882.46 -1.95% Apr 30, 2026
AGP Limited Rs 181.71 -2.04% Apr 30, 2026
BF Biosciences Limited Rs 133.60 -3.18% Apr 30, 2026
Citi Pharma Limited Rs 73.78 -3.56% Apr 30, 2026
Ferozsons Laboratories Limited Rs 361.38 -5.93% Apr 30, 2026
Glaxosmithkline Rs 340.77 -1.77% Apr 30, 2026
Glaxo Healthcare Pakistan Rs 120.23 -3.20% Jan 30, 2023
Haleon Pakistan Limited Rs 734.90 -0.96% Apr 30, 2026
Highnoon Laboratories Rs 913.44 -3.34% Apr 30, 2026
Hoechst Pakistan Limited Rs 3,982.85 -0.30% Apr 30, 2026
IBL Healthcare Limited Rs 45.48 -3.23% Apr 30, 2026
IBL Healthcare Limited (r) Rs 0.00 0.00% May 01, 2026
Liven Pharma Limited Rs 36.13 -7.24% Apr 30, 2026
Liven Pharma Limited (r) Rs 0.00 0.00% May 01, 2026
Macter International Limited Rs 271.43 -2.40% Apr 30, 2026
 

Shareholding Pattern

Year Individual Institutions Investment Companies Foreign Investors Government Shareholders Other